Related Experiment Video
Updated: Apr 15, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Genetic study of complex diseases in the post-GWAS era
1College of Life Sciences, Central China Normal University, Wuhan 430079, China.
Genome-wide association studies (GWASs) identify genetic variants linked to complex diseases. This review focuses on understanding the functional roles of non-coding regulatory single nucleotide polymorphisms (SNPs) identified by GWASs.
Area of Science:
- Genetics
- Genomics
- Bioinformatics
Background:
- Genome-wide association studies (GWASs) have identified thousands of genetic variants, primarily single nucleotide polymorphisms (SNPs), associated with complex human diseases.
- Understanding the functional consequences and mechanisms of these identified SNPs and genes is a critical challenge in disease research.
Purpose of the Study:
- To review recent advancements in understanding the functional impacts of GWAS-associated non-coding regulatory SNPs.
- To discuss the utility of systems genetics and network biology approaches for interpreting GWAS findings.
Main Methods:
- Literature review of functional characterization studies for GWAS-identified SNPs.
- Discussion of systems genetics and network biology methodologies.
Main Results:
- SNPs in protein-coding genes can alter amino acids, significantly impacting protein function and disease pathogenesis.
- Regulatory SNPs exert complex effects on gene expression via mechanisms including RNA splicing, transcription factor binding, DNA methylation, and miRNA recruitment.
Conclusions:
- Functional elucidation of non-coding regulatory SNPs is essential for understanding complex disease mechanisms.
- Systems genetics and network biology offer powerful frameworks for interpreting large-scale GWAS data and uncovering gene function.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Genomics
Single Nucleotide Polymorphisms-SNPs
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Pharmacogenetics and Pharmacogenomics: Overview

